Remember that automatic translation may not be accurate.
1315 Capital is the renowned VC, which was created in 2014. The fund is located in United States, North America. The main office of this VC is situated in Philadelphia.
The fund typically invests in rounds with 2-3 participants. Aside from 1315 Capital, start-ups are often funded by Split Rock Partners, Montreux Equity Partners, Longwood Founders Fund. The most common co-investors for the fund are Montreux Equity Partners, Longitude Capital, Horizon Technology Finance. In subsequent rounds, the fund is usually joined by Canaan Partners, 3D Systems.
In real terms, this VC performs 20 percentage points more exits than other funds. At the time of investment by 1315 Capital, a typical start-up valuation would be 50-100 millions dollars. The fund's activity peaked in 2017. Additionally, in 2019 the fund was active. The fund typically enters into less than 2 deals annually. Typical investments for this fund are deals in the range of 10 - 50 millions dollars. 1315 Capital is involved in 9 percentage points less than the average amount of lead investments when compared with other funds. We recorded the biggest number of exits for this fund in 2012.
Among their most successful investment fields, we have identified Cosmetics, Medical. Also, because of its portfolio diversification tendency, we can highlight 8 more industries for this fund. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. Colorescience, Onkos Surgical, Encore Dermatology are amongst the various portfolio companies of this fund. The average start-up age at the time of investment by this fund is 6-10. The fund has an exact preference in the amount of founders of companies in its portfolio.